flow trial semaglutide kidney outcomes hazard ratio 0.76 nejm 2024 Microaxial Pump or Standard Care in Infarct-Related Cardiogenic Shock FLOW trial Ozempic® (semaglutide injection)

A qualifying BMI or related health condition is typically required GLP-1 medications like semaglutide are usually prescribed to adults with a BMI over 30, or over 27 if they have a weight-related condition, such as high blood pressure, prediabetes, sleep apnea, or PCOS

Tirzepatide is a simple, once-weekly self-administered injection

[8] There is no established direct pharmacological mechanism by which GLP-1 receptor agonists affect the menstrual cycle or reproductive hormones, and menstrual disorders are not listed as common adverse reactions in UK product information

Damages in an Ozempic lawsuit may include compensation for: Past and Future Medical Bills: Individuals who require medical attention as a result of Ozempic use may qualify for compensation related to past medical bills and future treatment, including any surgeries needed to reverse the effects of the drug